Ometid 40 mg (Capsule (Enteric Coated))
Unit Price: ৳ 7.03 (3 x 10: ৳ 210.90)
Strip Price: ৳ 70.30
Medicine Details
Category | Details |
---|---|
Generic | Omeprazole |
Company | Opsonin pharma ltd |
Also available as |
Indications
- Gastric and duodenal ulcer
- NSAID-associated duodenal and gastric ulcer
- Gastro-esophageal reflux disease
- Acid-related dyspepsia
- Severe ulcerating reflux esophagitis
- Prophylaxis of acid aspiration during general anesthesia
- Zollinger-Ellison syndrome
- Helicobacter pylori-induced peptic ulcer
Pharmacology
- Inhibitor of gastric acid secretion
- Blocker of hydrogen-potassium-adenosine triphosphatase (H+/K+ ATPase) enzyme system
- Onset of antisecretory effect within one hour
- Maximum effect occurring within two hours
- Inhibition of secretion lasts up to 72 hours
Dosage
- Oral administration
- Dosage range for different indications
- Maintenance dose for recurrent duodenal ulcer
Administration
- IV Injection direction
- IV Infusion direction
- Restrictions on co-administration with other drugs
Interaction
- Impact on absorption of ketoconazole
- Metabolism through cytochrome P450
- Potential delay in elimination of diazepam, phenytoin, and warfarin
- Concomitant treatment with Ometid and clarithromycin
- Interactions with various substances and medications
Contraindications
- Known hypersensitivity to omeprazole
- Need to exclude malignancy before treatment in suspected cases of gastric ulcer
Side Effects
- Skin reactions such as rash, urticaria, and pruritus
- Photosensitivity, bullous eruption, erythema multiforme
- Gastrointestinal reactions including constipation, nausea, and abdominal pain
- Neurological symptoms like headache and paraesthesia
- Psychological effects like depression and hallucinations
- Hematological and hepatic reactions
Pregnancy & Lactation
- No adverse effects on pregnancy or health of the fetus/newborn child
- Use during pregnancy with caution
- Discontinuation of breastfeeding if essential
Precautions & Warnings
- Avoid concomitant use with clopidogrel
- Association with increased risk of osteoporosis-related fractures
- Not established safety and effectiveness in pediatric patients
Therapeutic Class
- Proton Pump Inhibitor
Storage Conditions
- Dry place away from light and heat
- Keep out of the reach of children
Related Brands
- Ometid 40 mg/vial (IV Injection) - opsonin-pharma-ltd
- Ometop 20 mg (Capsule (Enteric Coated)) - novus-pharmaceuticals-ltd
- Ometor 20 mg (Capsule (Enteric Coated)) - astra-biopharmaceuticals-ltd
- Omevir 20 mg (Capsule (Enteric Coated)) - virgo-pharmaceuticals-ltd
- Omex 20 mg (Capsule (Enteric Coated)) - kemiko-pharmaceuticals-ltd